Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)
CUSIP: 603380205
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 45,675,986
- Total 13F shares
- 2,269,165
- Share change
- +2,269,165
- Total reported value
- $7,508,000
- Price per share
- $3.31
- Number of holders
- 20
- Value change
- +$7,508,000
- Number of buys
- 20
Quarterly Holders Quick Answers
What is CUSIP 603380205?
CUSIP 603380205 identifies NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2022
Recent filing periods for CUSIP 603380205:
Top shareholders of NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. |
13F
|
Company |
22%
|
9,610,200
|
$7,976,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.9%
|
3,936,640
|
$3,268,000 | — | 31 Mar 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
4%
|
1,768,685
|
$1,465,000 | — | 31 Mar 2022 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
2.3%
|
1,024,000
|
$850,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.8%
|
788,077
|
$654,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.1%
|
501,876
|
$417,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
0.91%
|
401,027
|
$333,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.88%
|
389,952
|
$324,000 | — | 31 Mar 2022 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.69%
|
303,981
|
$252,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
303,218
|
$251,000 | — | 31 Mar 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
129,200
|
$107,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.25%
|
109,762
|
$91,000 | — | 31 Mar 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.21%
|
91,355
|
$76,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
65,413
|
$54,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.13%
|
56,292
|
$47,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
55,746
|
$46,000 | — | 31 Mar 2022 | |
| BAILARD, INC. |
13F
|
Company |
0.06%
|
24,400
|
$20,000 | — | 31 Mar 2022 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
0.05%
|
24,000
|
$20,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
19,705
|
$16,000 | — | 31 Mar 2022 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.04%
|
17,123
|
$14,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
15,506
|
$13,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
14,733
|
$12,000 | — | 31 Mar 2022 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.03%
|
13,900
|
$12,000 | — | 31 Mar 2022 | |
| Good Life Advisors, LLC |
13F
|
Company |
0.02%
|
10,000
|
$8,000 | — | 31 Mar 2022 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.02%
|
9,400
|
$7,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
4,335
|
$4,000 | — | 31 Mar 2022 | |
| TFC Financial Management, Inc. |
13F
|
Company |
0%
|
1,488
|
$1,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
647
|
$1,000 | — | 31 Mar 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
533
|
$442 | — | 31 Mar 2022 | |
| Anchor Investment Management, LLC |
13F
|
Company |
0%
|
100
|
$83 | — | 31 Mar 2022 | |
| William F. Doyle |
3/4/5
|
Director |
—
class O/S missing
|
2,500
|
— | — | 10 Jun 2022 |
Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) as of Q2 2022
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q4 2025 Across Filers
| Investor | Q4 2025 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.